MIGLUSTAT GEN.ORPH 100 mg, hard capsule 84 capsules
Active ingredients: Miglustat
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule84 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MIGLUSTAT GEN.ORPH 100 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- Plaquette(s) thermoformée(s) OPA : polyamide orienté aluminium PVC de 84 (7x12) gélule(s)
- Marketing authorisation holder
- GEN.ORPH
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Jul 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61255179CIP73013096CIP133400930130964Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MIGLUSTATgélule | 100 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.